|
1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016 Jul; 66(4): 271-89. doi:10.3322/caac.21349 2. Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol. 2010; 596: 467-88. doi:10.1007/978-1-60761-416-6_21 3. Baytas SN, Inceler N, Yilmaz A, Olgac A, Menevse S, Banoglu E, et al. Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry. 2014; 22(12): 3096-3104. https://doi.org/10.1016/j.bmc.2014.04.027 4. Borji A, Bayat M, Shamsabadi F, Amini F, Dayyani M, Mehrad Majd H. [Epidemiology of gastrointestinal cancers (stomach, esophageal and colorectal) in Neyshabur city during 2006-2012]. J Neyshabur Univ Med Sci. 2016; 3(4): 37-44. [Article in Persian] 5. Li C, Wang Y, Wang C, Yi X, Li M, He X. Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells. Phytomedicine. 2017 May; 28: 10-18. doi:10.1016/j.phymed.2017.02.008 6. Kumar NP, Sharma P, Reddy TS, Nekkanti S, Shankaraiah N, Lalita G, et al. Synthesis of 2, 3, 6, 7-tetramethoxyphenanthren-9-amine: An efficient precursor to access new 4-aza-2, 3-dihydropyridophenanthrenes as apoptosis inducing agents. EurJ Med Chem. 2017; 127: 305-17. https://doi.org/10.1016/j.ejmech.2017.01.001 7. Sharma P, Thummuri D, Reddy TS, Senwar KR, Naidu VGM, Srinivasulu G, et al. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies. Eur J Med Chem. 2016 Oct; 122: 584-600. doi:10.1016/j.ejmech.2016.07.019 8. Zhang B, Huang R, Hua J, Liang H, Pan Y, Dai L, et al. Antitumor lignanamides from the aerial parts of Corydalis saxicola. Phytomedicine. 2016 Dec; 23(13): 1599-609. doi:10.1016/j.phymed.2016.09.006 9. Borska S, Chmielewska M, Wysocka T, Drag-Zalesinska M, Zabel M, Dziegiel P. In vitro effect of quercetin on human gastric carcinoma: targeting cancer cells death and MDR. Food Chem Toxicol. 2012 Sep; 50(9): 3375-83. doi:10.1016/j.fct.2012.06.035 10. Stanton RA, Gernert KM, Nettles JH, Aneja R. Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev. 2011 May; 31(3): 443-81. doi:10.1002/med.20242 11. Beutler JA, Cardellina JH, Lin CM, Hamel E, Cragg GM, Boyd MR. Centaureidin, a cytotoxic flavone from Polymnia fruticosa, inhibits tubulin polymerization. Bioorganic & Medicinal Chemistry Letters. 1993 Apr; 3(4): 581-84. https://doi.org/10.1016/S0960-894X(01)81233-6 12. Ferlin MG, Carta D, Bortolozzi R, Ghodsi R, Chimento A, Pezzi V, et al. Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors. J Med Chem. 2013 Oct; 56(19): 7536-51. doi:10.1021/jm400377z 13. Ghodsi R, Azizi E, Zarghi A. Design, synthesis and biological evaluation of 4-(Imidazolylmethyl)-2-(4-methylsulfonyl phenyl)-Quinoline derivatives as selective COX-2 inhibitors and in-vitro anti-breast cancer agents. Iran J Pharm Res. 2016; 15(1): 169-77. 14. Malayeri SO, Abnous K, Arab A, Akaberi M, Mehri S, Zarghi A, et al. Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents. Bioorg Med Chem. 2017 Feb; 25(3): 1294-302. doi:10.1016/j.bmc.2016.12.050 15. Shobeiri N, Rashedi M, Mosaffa F, Zarghi A, Ghandadi M, Ghasemi A, et al. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors. Eur J Med Chem. 2016 May; 114: 14-23. doi:10.1016/j.ejmech.2016.02.069 16. Aboul-Enein MN, El-Azzouny AM, Ragab FA, Hamissa MF. Design, synthesis, and cytotoxic evaluation of certain 7-chloro-4-(piperazin-1-yl)quinoline derivatives as VEGFR-II inhibitors. Arch Pharm (Weinheim). 2017 Apr; 350(3-4). doi:10.1002/ardp.201600377 17. Alegaon SG, Parchure P, Araujo LD, Salve PS, Alagawadi KR, Jalalpure SS, et al. Quinoline-azetidinone hybrids: Synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines. Bioorg Med Chem Lett. 2017 Apr; 27(7): 1566-71. doi:10.1016/j.bmcl.2017.02.043 18. Gu W, Jin XY, Li DD, Wang SF, Tao XB, Chen H. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid. Bioorg Med Chem Lett. 2017 Sep; 27(17): 4128-32. doi:10.1016/j.bmcl.2017.07.033 19. Afzal O, Kumar S, Haider MR, Ali MR, Kumar R, Jaggi M, Bawa S. A review on anticancer potential of bioactive heterocycle quinoline. Eur J Med Chem. 2015 Jun; 97: 871-910. doi:10.1016/j.ejmech.2014.07.044 20. Kumar S, Guru SK, Venkateswarlu V, Malik F, Vishwakarma RA, Sawant SD, et al. A Novel Quinoline based second-generation mTOR inhibitor that induces apoptosis and disrupts PI3K-Akt-mTOR signaling in human leukemia HL-60 cells. Anticancer Agents Med Chem. 2015; 15(10): 1297-304. 21. Liu CY, Wu PT, Wang JP, Fan PW, Hsieh CH, Su CL, et al. An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions. Apoptosis. 2015 Nov; 20(11): 1471-82. doi:10.1007/s10495-015-1165-6 22. RohitKumar HG, Asha KR, Kiran Kumar HN, Inamdar LS, Rao GM. Cell cycle arrest and induction of apoptosis in colon adenocarcinoma cells by a DNA intercalative Quinoline derivative, 4-Morpholinopyrimido [4',5':4,5] Selenolo (2,3-b) Quinoline. Nucleosides Nucleotides Nucleic Acids. 2015; 34(8): 525-43. doi:10.1080/15257770.2015.1030503 23. RohitKumar HG, Asha KR, Raghavan SC, Advi Rao GM. DNA intercalative 4-butylaminopyrimido[4',5':4,5]thieno(2,3-b)quinoline induces cell cycle arrest and apoptosis in leukemia cells. Cancer Chemother Pharmacol. 2015 Jun; 75(6): 1121-33. doi:10.1007/s00280-015-2735-6 24. Sharma S, Panjamurthy K, Choudhary B, Srivastava M, Shahabuddin M, Giri R, et al. A novel DNA intercalator, 8-methoxy pyrimido[4',5':4,5]thieno (2,3-b)quinoline-4(3H)-one induces apoptosis in cancer cells, inhibits the tumor progression and enhances lifespan in mice with tumor. Mol Carcinog. 2013 Jun; 52(6): 413-25. doi:10.1002/mc.21867 25. Chen YF, Lin YC, Huang PK, Chan HC, Kuo SC, Lee KH, et al. Design and synthesis of 6,7-methylenedioxy-4-substituted phenylquinolin-2(1H)-one derivatives as novel anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase. Bioorg Med Chem. 2013 Sep; 21(17): 5064-75. doi:10.1016/j.bmc.2013.06.046 26. Hsu SC, Yu CC, Yang JS, Lai KC, Wu SH, Lin JJ, et al. A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells. Int J Oncol. 2012 Mar; 40(3): 731-38. doi:10.3892/ijo.2011.1241 27. Huang SM, Yang JS, Tsai SC, Chen MH, Hsu MH, Lin HY, et al. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells. Int J Oncol. 2011 May; 38(5): 1357-64. doi:10.3892/ijo.2011.952 28. Seo KW, Holt R, Jung YS, Rodriguez Jr CO, Chen X, Rebhun RB. Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines. PloS one. 2012; 7(8): e 42960. doi:10.1371/journal.pone.0042960 29. Xiang Q, Zhen Z, Deng DY, Wang J, Chen Y, Li J, et al. Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015; 34: 118. doi:10.1186/s13046-015-0238-2 30. Karthikeyan C, Lee C, Moore J, Mittal R, Suswam EA, Abbott KL, et al. IND-2, a pyrimido[1'',2'':1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells. Bioorg Med Chem. 2015 Feb; 23(3): 602-11. 31. Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, et al. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity. Bioorg Med Chem. 2009 Nov; 17(22): 7698-710. doi:10.1016/j.bmc.2009.09.039
|
